Welcome to Markets Desk, here's what's moving the tape.
Disney shares staged a meaningful rally Wednesday after the company delivered earnings that caught Wall Street off guard. Management pointed to the franchise pipeline, including Toy Story Five, as evidence the studio engine is firing again. The stock has been a persistent laggard this year, so this print carries real weight for sentiment.
Shifting to pharma, Eli Lilly reported revenue up forty-eight percent, fueled almost entirely by surging demand for its GLP-one drugs Mounjaro and Zepbound. The numbers came in ahead of even optimistic forecasts, reinforcing that the weight-loss and diabetes drug category is not a trend — it is a structural revenue story that rivals are still scrambling to match.
Meanwhile, Meta Platforms closed out an eleven-day losing streak in July that stripped nearly eighteen billion dollars from Mark Zuckerberg's net worth. The pressure point is AI capital expenditure — investors are watching spend scale faster than returns materialize. The question hanging over the stock is whether the market is losing patience with a long-horizon bet that has no near-term payoff visible.
That's the tape. Markets Desk, signing off the floor.
